Professor of Psychiatry & Pharmacology, Co-Chair

Roger S McIntyre

Dr Roger S McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto, Head of the Mood Disorders Psychopharmacology Unit at the University Health network, Toronto, and Co-Chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Co-morbidity in Adults with Major Depressive Disorder or Bipolar Disorder.

Dr McIntyre was named by Thomson Reuters in 2014 as one of ‘The World’s Most Influential Scientific Minds’.

Dr McIntyre was named by Thomson Reuters in 2014 as one of “The World’s Most Influential Scientific Minds”. He has published hundreds of peer-reviewed articles and edited/co-edited several textbooks on mood disorders.

 

Disclosures

Disclosures

Company

Research or grants from private industries or non-profit funds

Stanley Medical Research Institute; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institutes of Mental Health; Canadian Institutes of Health Research

Advisory boards

Bristol-Myers Squibb; Eli Lilly; Forest; Lundbeck; Merck; Otsuka; Pfizer; Shire; Sunovion; Takeda

Speaker Bureaus

AstraZeneca; Eli Lilly; Forest; Janssen-Ortho; Lundbeck; Merck; Otsuka; Pfizer; Sunovion; Takeda

CME activities

AstraZeneca; Bristol-Myers Squibb; Physicians’ Postgraduate Press; CME Outfitters; Merck; Eli Lilly; Pfizer; Lundbeck; Otsuka

Research grants

Eli Lilly; Janssen-Ortho; Shire; AstraZeneca; Pfizer; Lundbeck; Forest; Sunovion; BMS

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind